352 related articles for article (PubMed ID: 29199012)
1. Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion.
Willoughby AS; Vuong VS; Cunefare D; Farsiu S; Noronha G; Danis RP; Yiu G
Am J Ophthalmol; 2018 Feb; 186():144-151. PubMed ID: 29199012
[TBL] [Abstract][Full Text] [Related]
2. Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled Study.
Barakat MR; Wykoff CC; Gonzalez V; Hu A; Marcus D; Zavaleta E; Ciulla TA
Ophthalmol Retina; 2021 Jan; 5(1):60-70. PubMed ID: 32829027
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous intravitreal dexamethasone and aflibercept for refractory macular edema secondary to retinal vein occlusion.
Giuffrè C; Cicinelli MV; Marchese A; Coppola M; Parodi MB; Bandello F
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):787-793. PubMed ID: 31897703
[TBL] [Abstract][Full Text] [Related]
4. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders.
Tewari HK; Sony P; Chawla R; Garg SP; Venkatesh P
Eur J Ophthalmol; 2005; 15(5):619-26. PubMed ID: 16167293
[TBL] [Abstract][Full Text] [Related]
6. Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab.
Yoo SG; Kim JH; Lee TG; Kim CG; Kim JW
Indian J Ophthalmol; 2015 Jan; 63(1):25-9. PubMed ID: 25686058
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
8. Suprachoroidal Space Alterations Following Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients With Diabetic Macular Edema.
Lampen SIR; Khurana RN; Noronha G; Brown DM; Wykoff CC
Ophthalmic Surg Lasers Imaging Retina; 2018 Sep; 49(9):692-697. PubMed ID: 30222804
[TBL] [Abstract][Full Text] [Related]
9. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O
Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114
[TBL] [Abstract][Full Text] [Related]
10. Flare levels after intravitreal injection of ranibizumab, aflibercept, or triamcinolone acetonide for diabetic macular edema.
Morioka M; Takamura Y; Yamada Y; Matsumura T; Gozawa M; Inatani M
Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2301-2307. PubMed ID: 30238189
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M
Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711
[TBL] [Abstract][Full Text] [Related]
12. Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study.
Khurana RN; Chang LK; Bansal AS; Palmer JD; Wu C; Wieland MR
Ophthalmol Retina; 2018 Feb; 2(2):128-133. PubMed ID: 31047339
[TBL] [Abstract][Full Text] [Related]
13. Suprachoroidal triamcinolone acetonide for the treatment of macular edema associated with retinal vein occlusion: a pilot study.
Ali BM; Azmeh AM; Alhalabi NM
BMC Ophthalmol; 2023 Feb; 23(1):60. PubMed ID: 36765332
[TBL] [Abstract][Full Text] [Related]
14. Changes in choroidal structure following intravitreal aflibercept therapy for retinal vein occlusion.
Mitamura Y; Enkhmaa T; Sano H; Niki M; Murao F; Egawa M; Sonoda S; Sakamoto T
Br J Ophthalmol; 2021 May; 105(5):704-710. PubMed ID: 32620686
[TBL] [Abstract][Full Text] [Related]
15. Sustained-release intravitreal liquid drug delivery using triamcinolone acetonide for cystoid macular edema in retinal vein occlusion.
Lim JI; Fung AE; Wieland M; Hung D; Wong V
Ophthalmology; 2011 Jul; 118(7):1416-22. PubMed ID: 21397950
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
[TBL] [Abstract][Full Text] [Related]
17. Comparison of choroidal thickness changes following intravitreal dexamethasone, ranibizumab, and triamcinolone in eyes with retinal vein occlusion.
Yumusak E; Ornek K; Dikel NH
Eur J Ophthalmol; 2016 Nov; 26(6):627-632. PubMed ID: 26847213
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
19. SUPRACHOROIDAL INJECTION OF TRIAMCINOLONE ACETONIDE, CLS-TA, FOR MACULAR EDEMA DUE TO NONINFECTIOUS UVEITIS: A Randomized, Phase 2 Study (DOGWOOD).
Yeh S; Kurup SK; Wang RC; Foster CS; Noronha G; Nguyen QD; Do DV;
Retina; 2019 Oct; 39(10):1880-1888. PubMed ID: 30113933
[TBL] [Abstract][Full Text] [Related]
20. Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.
Scott IU; VanVeldhuisen PC; Ip MS; Blodi BA; Oden NL; King J; Antoszyk AN; Peters MA; Tolentino M;
JAMA Ophthalmol; 2017 Jun; 135(6):639-649. PubMed ID: 28492860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
